Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in LSTA — Lisata Therapeutics, Inc.

CIK 1533421 NEW YORK, NY
Back to LSTA Full portfolio

Position in LSTA

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$2,468
-$1,464 QoQ
Shares Held
726
-7.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 31 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LSTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,739,988 across 466 Biotechnology names. LSTA ranks #421 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in LSTA

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,468 726
2026-03-31 $3,932 785
2025-12-31 $4,746 2,552
2025-09-30 $4,378 1,671
2025-06-30 $3,836 1,323
2025-03-31 $5,186 2,207
2024-12-31 $5,706 1,915
2024-09-30 $4,578 1,526
2024-06-30 $1,526 440
2024-03-31 $2,661 853
2023-12-31 $2,809 1,029
2023-06-30 $3,921 1,060
2023-03-31 $2 691
2022-12-31 $4,037 1,596